(Updated - October 30, 2024 7:01 AM EDT)

William Blair analyst Tim F. Lugo downgraded BioMarin Pharmaceutical Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE